Small Bowel Obstruction and Surgery
|ClinicalTrials.gov Identifier: NCT03826251|
Recruitment Status : Completed
First Posted : February 1, 2019
Last Update Posted : February 1, 2019
Postoperative management after small bowel obstruction (SBO) surgery is not consensual and better knowledge of risk factors for postoperative morbidity could help to add evidence of the feasibility of enhanced recovery programs (ERPs).
In elective surgery, ERPs have shown a significant benefit for the patient but this is not performed routinely in emergency surgery due to the difficulty to avoid postoperative nasogastric tube.
The aim was to identify risk factors for postoperative morbidity and for nasogastric tube (NGT) replacement after SBO surgery.
|Condition or disease||Intervention/treatment|
|Acute Small Intestine Obstruction||Procedure: Nasogastric tube removal|
|Study Type :||Observational|
|Enrollment :||190 participants|
|Official Title:||Nasogastric Tube After Small Bowel Obstruction Surgery is Not Mandatory: a Retrospective Cohort Study|
|Actual Study Start Date :||January 1, 2014|
|Actual Primary Completion Date :||December 31, 2017|
|Actual Study Completion Date :||June 1, 2018|
systematic nasogastric tube
NGT was left systematically after surgery and removed after the first flattus
Non systematic nasogastric tube
Nasogastric tube was removed immediately after surgery and was replaced in case of vomiting
Procedure: Nasogastric tube removal
Nasogastric tube was removed immediately after surgery
- postoperative morbidity [ Time Frame: within 30 days ]morbidity classified according to Dindo Clavien classification
- Nasogastric tube replacement [ Time Frame: within 30 days ]nasogastric tube replacement after removal